TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32201120

Group type: EXPERIMENTAL
Intervention: Hypertensive patients with eGFR<60mL/min per 1.73m2
Number of subjects: 3006

Group type: EXPERIMENTAL
Intervention: Hypertensive patients aged ≥65 years
Number of subjects: 3006

Group type: EXPERIMENTAL
Intervention: Hypertensive male patients
Number of subjects: 3006

Group type: EXPERIMENTAL
Intervention: Hypertensive patients with educational level <6 years
Number of subjects: 3006

Group type: EXPERIMENTAL
Intervention: Hypertensive patients who smoke
Number of subjects: 3006
Study: 36109142

Group type: EXPERIMENTAL
Intervention: OKZ 64 mg once every 2 weeks (q2w)
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: OKZ 64 mg once every 4 weeks (q4w)
Number of subjects: 368

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: OKZ (both dosing regimens)
Number of subjects: 368
Study: 33317342

Group type: EXPERIMENTAL
Intervention: Jet injector of insulin glargine (12-18 IU/day)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Insulin pen
Number of subjects: 66
Study: 33232964

Group type: EXPERIMENTAL
Intervention: High vitamin K1 diet (4-week intervention of increased leafy green vegetable intake)
Number of subjects: 30
Study: 35201920

Group type: EXPERIMENTAL
Intervention: MitoQ (20 mg/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 32875670

Group type: EXPERIMENTAL
Intervention: Robotic manipulation
Number of subjects: 27

Group type: COMPARATOR
Intervention: Conventional manipulation
Number of subjects: 27
Study: 37770963

Group type: EXPERIMENTAL
Intervention: Telerehabilitation exercise program
Number of subjects: 70

Group type: COMPARATOR
Intervention: Digital booklet with self-care information
Number of subjects: 70
Study: 33276115

Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tongue scraping (standard treatment)
Number of subjects: 40
Study: 34698371

Group type: EXPERIMENTAL
Intervention: Tralokinumab 300 mg plus topical corticosteroids (TCS) as needed
Number of subjects: 277

Group type: COMPARATOR
Intervention: Placebo plus TCS as needed
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Tralokinumab plus TCS
Number of subjects: 277

Group type: COMPARATOR
Intervention: Placebo plus TCS
Number of subjects: 277
Study: 33175478

Group type: EXPERIMENTAL
Intervention: Prewiring Updated Logistic Clinical SYNTAX score (LCSS)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Postwiring Updated LCSS
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Prewiring MI-SYNTAX score
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Postwiring MI-SYNTAX score
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Prewiring Updated LCSS
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Four scores combined
Number of subjects: 512
Study: 35731044

Group type: EXPERIMENTAL
Intervention: Breast milk taste and smell administered together
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Breast milk taste
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no breast milk intervention)
Number of subjects: 0
Study: 36359816

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 33111337

Group type: EXPERIMENTAL
Intervention: DWP14012 (fexuprazan) 40 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: DWP14012 (fexuprazan) 80 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: DWP14012 (fexuprazan)
Number of subjects: 30
Study: 37715688

Group type: EXPERIMENTAL
Intervention: Training group with HPDs
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group with HPDs
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Training group in open ear condition
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group in open ear condition
Number of subjects: 50
Study: 33059496

Group type: EXPERIMENTAL
Intervention: Community-based intervention combining savings- and lending-groups, entrepreneurial training, and other skills training
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Community-based intervention
Number of subjects: 400
Study: 34104427

Group type: COMPARATOR
Intervention: Rice husk activated charcoal at 0%
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Rice husk activated charcoal at 1%
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Rice husk activated charcoal at 1.5%
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Rice husk activated charcoal at 2%
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Rice husk activated charcoal at 2.5%
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Rice husk activated charcoal at 3%
Number of subjects: 24
Study: 36053867

Group type: EXPERIMENTAL
Intervention: Digital cognitive behavioural therapy for insomnia (dCBT-I)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Sleep education (Control)
Number of subjects: 208
Study: 33397395

Group type: EXPERIMENTAL
Intervention: Dulaglutide (1.5 mg/day weekly)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 0
Study: 32513313

Group type: EXPERIMENTAL
Intervention: Dried fruit (3/4 cup/d mixed dried fruits: plums, figs, dates, and raisins)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control (energy- and carbohydrate-matched snack)
Number of subjects: 55
Study: 36018224

Group type: EXPERIMENTAL
Intervention: Deferiprone
Number of subjects: 134
Study: 33638769

Group type: EXPERIMENTAL
Intervention: Endoscopy plus partial splenic embolization (EP)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Endoscopic treatment (E)
Number of subjects: 102
Study: 35099442

Group type: EXPERIMENTAL
Intervention: Newly designed graphic and text warning label 'poverty'
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Newly designed label element 'dead person'
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Newly designed label element 'look after family'
Number of subjects: 388
Study: 34830530

Group type: EXPERIMENTAL
Intervention: Virtual supervised exercise program from 8–10 to 38–39 weeks of pregnancy
Number of subjects: 98
Study: 36270625

Group type: EXPERIMENTAL
Intervention: Video- and sensor-based feedback
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (overall results and matched training load)
Number of subjects: 26
Study: 33528102

Group type: EXPERIMENTAL
Intervention: Baby-friendly community initiative (BFCI) with standard maternal, infant and young child nutrition counselling, support from trained community health volunteers, health professionals and community and mother support groups
Number of subjects: 823

Group type: COMPARATOR
Intervention: Standard counselling only (control group)
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: Baby-friendly community initiative (BFCI)
Number of subjects: 823
Study: 34356994

Group type: EXPERIMENTAL
Intervention: Robot-Assisted Gait Training (RAGT) with physiotherapy
Number of subjects: 27

Group type: COMPARATOR
Intervention: Conventional gait training without RAGT
Number of subjects: 27
Study: 33571966

Group type: EXPERIMENTAL
Intervention: Transdermal buprenorphine 8.75 µg/h
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Transdermal buprenorphine 17.5 µg/h
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Transdermal buprenorphine 35 µg/h
Number of subjects: 60

Group type: COMPARATOR
Intervention: Transdermal buprenorphine 8.75 µg/h and 17.5 µg/h
Number of subjects: 60
Study: 35942633

Group type: EXPERIMENTAL
Intervention: Intracoronary tirofiban
Number of subjects: 180

Group type: COMPARATOR
Intervention: Intravenous tirofiban
Number of subjects: 180
Study: 34333845

Group type: EXPERIMENTAL
Intervention: Topical timolol maleate 0.5% eye drops
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 16
Study: 33173695

Group type: EXPERIMENTAL
Intervention: Silicone gel combined with pressure garment (PG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Silicone gel sheet combined with pressure garment (PG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pressure garment (PG) alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Silicone gel and silicone gel sheet combined with PG
Number of subjects: 0
Study: 34105213

Group type: EXPERIMENTAL
Intervention: Buprenorphine-naloxone (BUP)
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Methadone (MET)
Number of subjects: 597
Study: 34105081

Group type: EXPERIMENTAL
Intervention: Repaired tetralogy of Fallot (rTOF) patients
Number of subjects: 49
Study: 32982207

Group type: EXPERIMENTAL
Intervention: TIRE (advanced IMT electronic system PrO2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Threshold loading IMT protocols
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham training
Number of subjects: 0
Study: 35172870

Group type: EXPERIMENTAL
Intervention: Customized maxillary oral appliance (CMOA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mandibular advancement device (MAD)
Number of subjects: 40
Study: 34016156

Group type: EXPERIMENTAL
Intervention: Hand hygiene intervention
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (no hand hygiene intervention)
Number of subjects: 33
Study: 32267031

Group type: EXPERIMENTAL
Intervention: Aromatherapy with rose essence (0.2 ml)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Aromatherapy with lavender essence (0.2 ml)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Routine care (Control group)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo (cotton swab soaked in water)
Number of subjects: 160
Study: 33881810

Group type: EXPERIMENTAL
Intervention: Descemet membrane endothelial keratoplasty
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endothelial keratoplasty in 2 eyes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Posterior densitometry
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diagnosis of pseudophakic bullous keratopathy
Number of subjects: 0
Study: 34913883

Group type: EXPERIMENTAL
Intervention: Exercise combined with Acceptance and Commitment Therapy (ExACT)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Supervised exercise programme alone (Control)
Number of subjects: 175
Study: 33705985

Group type: EXPERIMENTAL
Intervention: HFRT (68 Gy in 25 fractions)
Number of subjects: 111

Group type: COMPARATOR
Intervention: CFRT (78 Gy in 39 fractions)
Number of subjects: 111
Study: 32161949

Group type: EXPERIMENTAL
Intervention: TD-1473 20 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TD-1473 80 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TD-1473 270 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34033301

Group type: EXPERIMENTAL
Intervention: Yacon flour (25g) with energy restricted diet
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (no yacon flour) with energy restricted diet
Number of subjects: 26
Study: 33320311

Group type: COMPARATOR
Intervention: PPE0 (no PPE)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PPE1 (improvised PPE)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PPE2 (off-the-shelf PPE)
Number of subjects: 30
Study: 36152058

Group type: EXPERIMENTAL
Intervention: Active warm-up (10 min cycling at 50% peak aerobic power)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control condition (no warm-up)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Time of day (morning vs. afternoon)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Post-exercise recovery
Number of subjects: 11
Study: 33998005

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser resurfacing
Number of subjects: 40

Group type: COMPARATOR
Intervention: Carboxytherapy
Number of subjects: 40
Study: 33318068

Group type: EXPERIMENTAL
Intervention: Oral semaglutide (dose-adjusted 3, 7, or 14 mg)
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Oral semaglutide (initiated at 3 mg)
Number of subjects: 382

Group type: COMPARATOR
Intervention: Sitagliptin (100 mg)
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Oral semaglutide
Number of subjects: 382

Group type: COMPARATOR
Intervention: Sitagliptin
Number of subjects: 382
Study: 33992267

Group type: EXPERIMENTAL
Intervention: Dry needling (DN) plus manual therapy (MT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Manual therapy (MT) alone
Number of subjects: 40
Study: 32265129

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT) boost treatment of 19.5 to 21 Gy in 3 fractions (1 fraction per week)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional fractionation (CF) external beam radiotherapy (EBRT) boost treatment of 32 to 33 Gy in 15 to 16 fractions
Number of subjects: 100
Study: 37704299

Group type: EXPERIMENTAL
Intervention: Rotational Atherectomy (RA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Orbital Atherectomy (OA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both RA and OA
Number of subjects: 0
Study: 33547228

Group type: EXPERIMENTAL
Intervention: Baseline MRI inflammation
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Baseline ultrasound inflammation
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Imaging inflammation in clinical remission
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Tenosynovitis
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Synovitis and tenosynovitis
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Imaging information
Number of subjects: 218
Study: 35639873

Group type: EXPERIMENTAL
Intervention: Enamel sandblasting
Number of subjects: 197

Group type: COMPARATOR
Intervention: Non-sandblasting (control)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Males
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Fair level of co‐operation
Number of subjects: 197
Study: 33415354

Group type: EXPERIMENTAL
Intervention: Aflibercept
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 362
Study: 32621047

Group type: EXPERIMENTAL
Intervention: Repaglinide
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Repaglinide-plus-acarbose
Number of subjects: 358
Study: 34983508

Group type: EXPERIMENTAL
Intervention: SMILE lifestyle intervention (12-month group-based intervention focusing on increased physical activity and healthy food intake)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: SMILE lifestyle intervention
Number of subjects: 15
Study: 32871761

Group type: EXPERIMENTAL
Intervention: Fresh group
Number of subjects: 3

Group type: COMPARATOR
Intervention: 5% DMSO group
Number of subjects: 3

Group type: COMPARATOR
Intervention: 10% DMSO group
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: All groups at 1st passage
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: All groups at 3rd passage
Number of subjects: 3
Study: 35603236

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 33036322

Group type: EXPERIMENTAL
Intervention: Random allocation of subcarriers in an OFDM-based CRN without spectrum-sensing mechanism
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: M-QAM modulation orders
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Different modulation orders of M-QAM
Number of subjects: 0
Study: 35596784

Group type: EXPERIMENTAL
Intervention: Hyperglycaemia (oral and intravenous glucose, target blood glucose > 25 mM for 2 hours)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Moxifloxacin (administered on day 3)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (administered on day 1)
Number of subjects: 21
Study: 34020929

Group type: EXPERIMENTAL
Intervention: 7-F transradial access (TRA)
Number of subjects: 388

Group type: COMPARATOR
Intervention: 7-F transfemoral access (TFA)
Number of subjects: 388
Study: 32611442

Group type: EXPERIMENTAL
Intervention: Voluntary Breathing Exercises (VBE)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Routine follow-up (Control)
Number of subjects: 140
Study: 35217325

Group type: EXPERIMENTAL
Intervention: Yoga for HEART
Number of subjects: 15

Group type: COMPARATOR
Intervention: Active Control
Number of subjects: 15
Study: 33010810

Group type: EXPERIMENTAL
Intervention: as-needed budesonide–formoterol 200–6 μg
Number of subjects: 5721

Group type: EXPERIMENTAL
Intervention: budesonide maintenance 200 μg twice daily plus as-needed terbutaline
Number of subjects: 5721

Group type: COMPARATOR
Intervention: as-needed terbutaline 0.5 mg
Number of subjects: 5721
Study: 35126880

Group type: EXPERIMENTAL
Intervention: Problem Management Plus (PM+)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Enhanced Treatment As Usual (ETAU)
Number of subjects: 59
Study: 33709262

Group type: EXPERIMENTAL
Intervention: GlideScope™ videolaryngoscopy (GVL)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Direct laryngoscopy using a Macintosh blade (MAC)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both GVL and MAC
Number of subjects: 50
Study: 32902572

Group type: EXPERIMENTAL
Intervention: Cold-stored platelets (2° to 6°C)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Room temperature-stored platelets (20° to 24°C)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cold-stored platelets (8 to 14 days)
Number of subjects: 40
Study: 36433897

Group type: EXPERIMENTAL
Intervention: Booster intervention delivered remotely by telephone in one session.
Number of subjects: 50
Study: 35035229

Group type: EXPERIMENTAL
Intervention: Suppository Diclofenac 100mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EMLA cream (5% Prilocaine/Lidocaine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34043401

Group type: EXPERIMENTAL
Intervention: personalized feedback plus interactive text messaging (PFT)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: personalized feedback only (PF)
Number of subjects: 77

Group type: COMPARATOR
Intervention: informational control (IC)
Number of subjects: 77
Study: 32510635

Group type: EXPERIMENTAL
Intervention: cord-RBCs
Number of subjects: 25

Group type: COMPARATOR
Intervention: adult-RBCs
Number of subjects: 25

Group type: COMPARATOR
Intervention: combined adult- and cord-RBCs
Number of subjects: 25
Study: 34764195

Group type: EXPERIMENTAL
Intervention: Adjuvant Pembrolizumab for one year
Number of subjects: 1301

Group type: COMPARATOR
Intervention: High-dose IFNα-2b for one year
Number of subjects: 1301

Group type: COMPARATOR
Intervention: Ipilimumab for up to three years
Number of subjects: 1301

Group type: EXPERIMENTAL
Intervention: Adjuvant Pembrolizumab
Number of subjects: 1301

Group type: COMPARATOR
Intervention: High-dose IFNα-2b
Number of subjects: 1301

Group type: COMPARATOR
Intervention: Ipilimumab
Number of subjects: 1301
Study: 34321730

Group type: EXPERIMENTAL
Intervention: Self-Care Interventional Package
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 115
Study: 34958368

Group type: EXPERIMENTAL
Intervention: Very low nicotine content (VLNC) cigarettes
Number of subjects: 58
Study: 32065311

Group type: EXPERIMENTAL
Intervention: Scaling and root planing for CPs and CPns
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral hygiene tutoring for CHs and CHns
Number of subjects: 40
Study: 35764194

Group type: EXPERIMENTAL
Intervention: Intensive exercise-based lifestyle intervention (5-6 aerobic sessions/week, 2-3 resistance training sessions/week, dietary intervention aiming at reduction of ∼500 kcal/day for months 0-4, isocaloric diet for months 5-12)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Standard care (individual education in diabetes management, advice on healthy lifestyle, medication regulation by a blinded endocrinologist)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Between group comparison
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 77
Study: 33582306

Group type: EXPERIMENTAL
Intervention: DilaCheck (novel device)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard manual examination
Number of subjects: 42
Study: 35114058

Group type: EXPERIMENTAL
Intervention: Rebozo intervention before ECV (n=187)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Control group (ECV alone, n=185)
Number of subjects: 372
Study: 33682192

Group type: EXPERIMENTAL
Intervention: Fiber-added formulas
Number of subjects: 83

Group type: COMPARATOR
Intervention: Fiber-free formulas
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Patients with diarrhea (any cause)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Patients with CDAD
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Medication associated diarrhea
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: CDAD
Number of subjects: 83
Study: 32439229

Group type: EXPERIMENTAL
Intervention: ROTEM (thromboelastometry) guided therapy
Number of subjects: 92

Group type: COMPARATOR
Intervention: Conventional laboratory tests (CLT)
Number of subjects: 92
Study: 33568467

Group type: EXPERIMENTAL
Intervention: Azithromycin treatment
Number of subjects: 344
Study: 32414376

Group type: COMPARATOR
Intervention: Basic educational materials alone (Arm 1)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Basic educational materials plus facilitation (Arm 2)
Number of subjects: 23
Study: 35331018

Group type: EXPERIMENTAL
Intervention: High-intensity resistance training (RT) at 70-80% of 1-repetition maximum (1-RM)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Low-intensity resistance training (RT) at 40-50% of 1-repetition maximum (1-RM)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (1200 International units vitamin D3 per day)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 177
Study: 36331685

Group type: EXPERIMENTAL
Intervention: Heart rate variability biofeedback (HRVB) intervention combined with treatment as usual
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (wait-list)
Number of subjects: 0
Study: 35728858

Group type: EXPERIMENTAL
Intervention: Intelligent Calculation (IC) method
Number of subjects: 200

Group type: COMPARATOR
Intervention: Traditional Calculation (TC) method
Number of subjects: 200
Study: 33444219

Group type: EXPERIMENTAL
Intervention: Point-of-care (POC) early infant diagnosis (EID) test (Xpert HIV-1 Qualitative assay)
Number of subjects: 18
Study: 34373214

Group type: EXPERIMENTAL
Intervention: Conservative treatment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Conservative treatment + medication
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Arthrocentesis
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Arthrocentesis + medication
Number of subjects: 60